CDER Compliance Office Director Must Recuse Herself From Most Duties
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS General Counsel determines that to prevent potential conflicts of interest Cynthia Schnedar must no longer handle substantive issues for compliance actions and policy.
You may also be interested in...
US FDA’s New Compliance Chief Donald Ashley Brings International Law Enforcement Experience
Ashley's many years in the Department of Justice’s Office of International Affairs should be a plus for agency's globalization efforts.
FDA Again Taps Compliance Director For Globalization Post
Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.
CDER’s New Compliance Director Sklamberg Brings Experience On Compounding Issues
Howard Sklamberg, deputy associate commissioner in FDA’s Office of Regulatory Affairs, will take over as director of the Center for Drug Evaluation and Research’s Compliance Office in January; acting compliance director Ilisa Bernstein will resume her role as deputy director.